Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2023 Mar;37(6):e24882.
doi: 10.1002/jcla.24882. Epub 2023 Apr 9.

Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-γ release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2

Affiliations
Comparative Study

Comparative analysis between STANDARD-E Covi-FERON ELISA with pre-existing IFN-γ release assays and determination of the optimum cutoff value for assessment of T-Cell response to SARS-CoV-2

Jieun Jang et al. J Clin Lab Anal. 2023 Mar.

Abstract

Background: Interferon-gamma (IFN-γ) release assays (IGRAs) are useful for the assessment of the T-cell response to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We aimed to assess the performance of the newly developed IGRA ELISA test compared to the pre-existing assays and to validate the cutoff value in real-world conditions.

Methods: We enrolled 219 participants and assessed agreement between STANDARD-E Covi-FERON ELISA with Quanti-FERON SARS-CoV-2 (QFN SARS-CoV-2), as well as with T SPOT Discovery SARS-CoV-2 based on Cohen's kappa-index. We further determined the optimal cutoff value for the Covi-FERON ELISA according to the immune response to vaccinations or infections.

Results: We found a moderate agreement between Covi-FERON ELISA and QFN SARS-CoV-2 before vaccination (kappa-index = 0.71), whereas a weak agreement after the first (kappa-index = 0.40) and second vaccinations (kappa-index = 0.46). However, the analysis between Covi-FERON ELISA and T SPOT assay demonstrated a strong agreement (kappa-index >0.7). The cut-off value of the OS (original spike) marker was 0.759 IU/mL with a sensitivity of 96.3% and specificity of 78.7%, and that of the variant spike (VS) marker was 0.663 IU/mL with a sensitivity and specificity of 77.8% and 80.6%, respectively.

Conclusion: The newly determined cut-off value may provide an optimum value to minimize and prevent the occurrence of false-negative or false-positive during the assessment of T-cell immune response using Covi-FERON ELISA under real-world conditions.

Keywords: COVID-19; T-cell response; cutoff value; interferon-gamma; interferon-gamma release assay; kappa-index.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

FIGURE 1
FIGURE 1
The receiver operating characteristic (ROC) curve of Covi‐FERON ELISA markers to discriminate individuals with and without a T‐cell immune response. (A) The optimal cutoff value of the Covi‐FERON ELISA original SARS‐CoV‐2‐spike protein (OS) marker is 0.759 IU/mL. (B) The optimal cutoff value of the Covi‐FERON ELISA variant SARS‐CoV‐2‐spike protein (VS) marker is 0.663 IU/mL.

Similar articles

Cited by

References

    1. Van Praet JT, Vandecasteele S, De Roo A, Vynck M, De Vriese AS, Reynders M. Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid‐19 vaccination in Covid‐19 naive nursing home residents. J Infect Dis. 2021;224(10):1690‐1693. - PubMed
    1. Collier A‐r Y, Yu J, McMahan K, et al. Differential kinetics of immune responses elicited by Covid‐19 vaccines. N Engl J Med. 2021;385(21):2010‐2012. - PMC - PubMed
    1. Zheng H‐Y, Xu M, Yang C‐X, et al. Longitudinal transcriptome analyses show robust T‐cell immunity during recovery from COVID‐19. Signal Transduct Target Ther. 2020;5(1):1‐12. - PMC - PubMed
    1. Sahin U, Muik A, Derhovanessian E, et al. COVID‐19 vaccine BNT162b1 elicits human antibody and TH1 T‐cell responses. Nature. 2020;586(7830):594‐599. - PubMed
    1. Ahmed SF, Quadeer AA, McKay MR. SARS‐CoV‐2 T‐cell responses elicited by COVID‐19 vaccines or infection are expected to remain robust against omicron. Viruses. 2022;14(1):79. - PMC - PubMed

Publication types

Substances